Incidence of atherosclerotic arterial occlusive accidents in predialysis and dialysis patients: A multicentric study in the Ile de France district

Nephrology Dialysis Transplantation

Volumn 14, Issue 4, 1999, Pages 898-902

  Jungers, Paul ^a   Khoa, Thao Nguyen ^a   Massy, Ziad A ^a   Zingraff, Johanna ^a   Labrunie, Mathilde ^a   Descamps Latscha, Béatrice ^a   Man, Ngugen K ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Accelerated atherosclerosis; Cardiovascular accidents; Cerebral infarction; Chronic renal failure; Maintenance haemodialysis; Myocardial infarction

Indexed keywords

ADULT; ARTERY OCCLUSION; ARTICLE; ATHEROSCLEROSIS; BRAIN INFARCTION; CONTROLLED STUDY; FEMALE; FRANCE; HEART INFARCTION; HEMODIALYSIS; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; UREMIA;

EID: 0032943645     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/14.4.898     Document Type: Article

References (20)

1. Lindner A, Charra B, Sherrard DJ, Scribncr BH. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 1974; 290: 697-701
2. Raine AEG, Margreiter R, Brunner FP et al. Report on management of renal failure in Europe, XXII, 1991. Nephrol Dial Transplant 1992; 7 [Suppl. 2]: 7-35
3. Rostand SG, Brunzell JD, Cannon RD, Victor RG. Cardiovascular complications in renal failure. J Am Soc Nephrol 1991; 2: 1053-1062
4. Parfrey PS, Harnett JD. Long-term cardiac morbidity and mortality during dialysis therapy. Adv Nephrol 1994; 23: 311-331
5. The USRDS 1997 Annual Data Report. Causes of death. Am J Kidney Dis 1997; 30 [Suppl. 1]: S107-117
6. Parfrey PS, Harnett JD, Foley RN. Heart failure and ischemic heart disease in chronic uremia. Curr Opin Nephrol Hypertens 1995; 4: 105-110
7. Ritz E, Wiecek A, Gnasso A, Augustin J. Is atherogenesis accelerated in uremia ? Contrib Nephrol 1986; 52: 1-9
8. Brown JH, Hunt LP, Vites NP, Short CD, Gokal R, Mallick NP. Comparative mortality from cardiovascular disease in patients with chronic renal failure. Nephrol Dial Transplant 1994; 9: 1136-1142
9. Fréquence et conditions d'hospitalisation des infarctus du myocarde récents en France: enquête nationale ENIM 1984. Groupe de travail 'Epidémiologie et Prévention' de la Société Française de Cardiologie. Arch Mal Coeur 1987; 80: 1853-1863
10. Jungers P, Hannedouche T, Itakura Y, Albouze G, Descamps-Latscha B, Man NK. Progression rate to end-stage renal failure in non-diabetic kidney diseases: a multivariate analysis of determinant factors. Nephrol Dial Transplant 1995; 10: 1353-1360
11. Rostand SG, Gretes JC, Kirk KA, Rutsky EA, Andreoli TE. Ischemic heart disease in patients with uremia undergoing maintenance hemodialysis. Kidney Int 1979; 16: 600-614
12. Ritz E, Augustin J, Bommer J, Gnasso A, Haberbosch W. Should hyperlipemia of renal failure be treated? Kidney Int 1985; 28 [Suppl 17]: S84-88
13. Ritz E, Koch M. Morbidity and mortality due to hypertension in patients with renal failure. Am J Kidney Dis 1993: 21 [Suppl. 2]: 113-118
14. Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray D, Barre PE. Outcome and risk factors of ischemic heart disease in chronic uremia. Kidney Int 1996; 49: 1428-1434
15. Massy Z, Jungers P, Roullet JB, Drüeke T, Lacour B. Disturbances of apolipoprotein distribution in lipoproteins of uremic patients. J Nephrol 1993; 6: 153-158
16. Attman PO, Samuelsson O, Alaupovic P. Lipoprotein metabolism and renal failure. Am J Kidney Dis 1993; 21: 573-592
17. Webb AT, Reaveley DA, O'Donnell M, O'Connor B, Seed M, Brown EA. Lipids and lipoprotein (a) as risk factors for vascular disease in patients on renal replacement therapy. Nephrol Dial Transplant 1994; 5: 354-357
18. Lip GYP. Fibrinogen and cardiovascular disorders. Q J Med 1995; 88: 155-165
19. Bachmann J, Tepel M, Raidt H et al. Hyperhomocysteinemia and the risk for vascular disease in hemodialysis patients. J Am Soc Nephrol 1995; 6: 121-125
20. Jungers P, Chauveau P, Chadefaux B et al. Hyperhomocysteinemia is associated with arterial occlusive accidents in predialysis chronic renal failure patients. Miner Electrolyte Metab 1997; 23: 170-173